GPCR
Price
$35.14
Change
-$0.78 (-2.17%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.18B
Intraday BUY SELL Signals
VKTX
Price
$39.01
Change
-$1.77 (-4.34%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
4.61B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs VKTX

Header iconGPCR vs VKTX Comparison
Open Charts GPCR vs VKTXBanner chart's image
Structure Therapeutics
Price$35.14
Change-$0.78 (-2.17%)
Volume$23.51K
Capitalization2.18B
Viking Therapeutics
Price$39.01
Change-$1.77 (-4.34%)
Volume$49.99K
Capitalization4.61B
GPCR vs VKTX Comparison Chart in %
View a ticker or compare two or three
VS
GPCR vs. VKTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Buy and VKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (GPCR: $35.92 vs. VKTX: $40.78)
Brand notoriety: GPCR and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 113% vs. VKTX: 112%
Market capitalization -- GPCR: $2.18B vs. VKTX: $4.61B
GPCR [@Biotechnology] is valued at $2.18B. VKTX’s [@Biotechnology] market capitalization is $4.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • GPCR’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GPCR and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 6 bullish TA indicator(s).

  • GPCR’s TA Score: 5 bullish, 4 bearish.
  • VKTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than GPCR.

Price Growth

GPCR (@Biotechnology) experienced а +11.52% price change this week, while VKTX (@Biotechnology) price change was +11.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

VKTX is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($4.61B) has a higher market cap than GPCR($2.18B). GPCR YTD gains are higher at: 32.448 vs. VKTX (1.342). VKTX (-212.42M) and GPCR (-218.56M) have comparable annual earnings (EBITDA) . VKTX (808M) and GPCR (786M) have equal amount of cash in the bank . VKTX has less debt than GPCR: VKTX (878K) vs GPCR (7.68M). GPCR (0) and VKTX (0) have equivalent revenues.
GPCRVKTXGPCR / VKTX
Capitalization2.18B4.61B47%
EBITDA-218.56M-212.42M103%
Gain YTD32.4481.3422,418%
P/E RatioN/AN/A-
Revenue00-
Total Cash786M808M97%
Total Debt7.68M878K874%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GPCRVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 21 days ago
89%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IENRX11.320.17
+1.52%
Macquarie Climate Solutions R6
TINRX48.790.03
+0.06%
Nuveen Equity Index A
PRCFX29.620.01
+0.03%
T. Rowe Price Cap Apprec And Inc
FTCEX14.63N/A
N/A
Fidelity Advisor Total Intl Equity C
TRHBX26.42-0.08
-0.30%
Nuveen Small Cap Blend Idx I

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+3.03%
CLDX - GPCR
44%
Loosely correlated
-0.49%
SYRE - GPCR
44%
Loosely correlated
+0.34%
IMTX - GPCR
43%
Loosely correlated
+16.10%
VKTX - GPCR
43%
Loosely correlated
+0.44%
EYPT - GPCR
42%
Loosely correlated
+2.96%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with SYRE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+0.44%
SYRE - VKTX
45%
Loosely correlated
+0.34%
NEVPF - VKTX
45%
Loosely correlated
N/A
GPCR - VKTX
43%
Loosely correlated
+3.03%
IMTX - VKTX
42%
Loosely correlated
+16.10%
RGNX - VKTX
40%
Loosely correlated
+0.43%
More